نتایج جستجو برای: antithyroid agents

تعداد نتایج: 361460  

2017
Asha Birmingham Carissa Mancuso Craig Williams

A comparison of this case to previously published reports suggests that granulocyte colony-stimulating factor may be associated with improved prognosis in severe antithyroid drug-induced neutropenia, and that weight-based doses could be an appropriate strategy.

2017
Maïa Banigé Candice Estellat Valerie Biran Luc Desfrere Valerie Champion Alexandra Benachi Yves Ville Marc Dommergues Pierre-Henri Jarreau Mostafa Mokhtari Claire Boithias Frederic Brioude Laurent Mandelbrot Pierre-François Ceccaldi Delphine Mitanchez Michel Polak Dominique Luton

Context Neonatal hyperthyroidism was first described in 1912 and in 1964 was shown to be linked to transplacental passage of maternal antibodies. Few multicenter studies have described the perinatal factors leading to fetal and neonatal dysthyroidism. Objective To show how fetal dysthyroidism (FD) and neonatal dysthyroidism (ND) can be predicted from perinatal variables, in particular, the le...

Journal: :European thyroid journal 2012
Kris Poppe Alicja Hubalewska-Dydejczyk Peter Laurberg Roberto Negro Francesco Vermiglio Bijay Vaidya

BACKGROUND An optimal management of maternal hyperthyroidism is important for positive pregnancy outcome, and to this end, the Endocrine Society published their guidelines in 2007. This survey aimed to investigate to what extent the clinical practice relating to the management of hyperthyroidism during pregnancy in Europe is uniform and consistent with the guidelines. MATERIALS AND METHODS We...

2014
Stine Linding Andersen Jørn Olsen Chun Sen Wu Peter Laurberg

OBJECTIVES Pregnancy loss in women suffering from hyperthyroidism has been described in case reports, but the risk of pregnancy loss caused by maternal hyperthyroidism in a population is unknown. We aimed to evaluate the association between maternal hyperthyroidism and pregnancy loss in a population-based cohort study. STUDY DESIGN All pregnancies in Denmark from 1997 to 2008 leading to hospi...

2012
Marta Baleva Krasimir Nikolov Emil Manov Anastas Stoikov Rebhat Shabani Lyubomir Dourmishev Milena Nikolova

We report four female patients with Graves' disease with positive ANA antibodies and possibility for development of systemic lupus erythematosus. All four patients have been treated with antithyroid drugs. SLE symptoms have appeared from 4 to 12 months after the beginning of therapy with methysol in two of them. The third patient had no symptoms for SLE, but her ANA, anti-DNA, and antihistone a...

2005
A. M. Ahmed N. H. Ahmed

1Faculty of Medicine, University of Bahr Elghazal, Khartoum, Sudan (Correspondence to A.M. Ahmed: [email protected]). Ministry of Health, Khartoum, Sudan. Received: 17/08/03; accepted: 22/03/04 ABSTRACT The first description of thyroid diseases as they are known today was that of Graves disease by Caleb Parry in 1786, but the pathogenesis of thyroid disease was not discovered until 1882–86. T...

Journal: :Kidney international 2003
Roland Schmitt Sebastian Bachmann

BACKGROUND Serum cystatin C (CysC) is a novel marker for kidney function that has been claimed to be superior to serum creatinine. Thyroid dysfunction may alter creatinine, which has been found to be increased in hypothyroidism and decreased in hyperthyroidism. This study was performed to evaluate whether changes in CysC and creatinine are parallel during the treatment of hypo- and hyperthyroid...

Journal: :The Ulster Medical Journal 1975
D. A. Montgomery

We have come a long way since Mackenzie wrote these words in 1905, and yet in one sense they are still true. It is not that the modern modes of treatment are of doubtful value; all are effective, but the ideal treatment for hyperthyroidism still eludes us. Neither do we have reliable methods of selecting the best treatment for the individual patient. This could be arranged more rationally if it...

2013
Sirianong Namwongprom Kevalee Unachak Prapai Dejkhamron Supoj Ua-apisitwong Molrudee Ekmahachai

OBJECTIVE The aim of the present study was to evaluate the outcome of radioiodine treatment in thyrotoxicosis in childhood and adolescence. METHODS This was a retrospective study of 27 patients (ages 7.2- 19.8 years) with a diagnosis of thyrotoxicosis who received iodine-131 (I-131) treatment from January 2007 to December 2011 in the Nuclear Medicine Division, Department of Radiology, Faculty...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید